Cargando…

An impaired hepatic clock system effects lipid metabolism in rats with nephropathy

Hyperlipidemia is a key clinical feature in patients with nephrotic syndrome (NS) that is associated with the incidence of cardiovascular events. Recent studies have suggested that the disorders of triglycerides, gluconeogenesis and liver glucose metabolism are associated with the abnormal transcrip...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Peipei, Zhang, Ruiyu, Mou, Lijun, Li, Xuewang, Qin, Yan, Li, Xuemei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6192718/
https://www.ncbi.nlm.nih.gov/pubmed/30132511
http://dx.doi.org/10.3892/ijmm.2018.3833
_version_ 1783363949517864960
author Chen, Peipei
Zhang, Ruiyu
Mou, Lijun
Li, Xuewang
Qin, Yan
Li, Xuemei
author_facet Chen, Peipei
Zhang, Ruiyu
Mou, Lijun
Li, Xuewang
Qin, Yan
Li, Xuemei
author_sort Chen, Peipei
collection PubMed
description Hyperlipidemia is a key clinical feature in patients with nephrotic syndrome (NS) that is associated with the incidence of cardiovascular events. Recent studies have suggested that the disorders of triglycerides, gluconeogenesis and liver glucose metabolism are associated with the abnormal transcription of clock genes. However, changes to the circadian rhythm of blood lipids in NS require further exploration, and the effects of NS on the hepatic clock system remain to be elucidated. In the present study, the impaired diurnal rhythm of the hepatic core clock genes (BMAL1, CLOCK, CRY1, CRY2, PER1 and PER2) significantly induced circadian rhythm abnormalities in liver-specific clock-controlled genes (LXR, CYP7A1, SREBP-1, ABCA1, DEC1 and DEC2; all P<0.05), which were significantly associated with the abnormal diurnal rhythms of triglyceride, total cholesterol, aspartate aminotransferase and alanine aminotransferase (all P<0.05) in rats with Adriamycin-induced nephropathy. Furthermore, a protein-protein interaction network was identified. Gene Ontology and Kyoto Encyclopedia of Genes and Genomes pathway analyses based on the human database was conducted to obtain signaling pathway and correlation prediction analyses of overall human clock and clock-controlled gene correlations. Strong correlations of the aforementioned clock genes were detected (avg. local clustering coefficient, 0.849) which suggested significant enrichment in circadian rhythm signaling. The present results indicated that damage to hepatic clock systems may impact blood lipid circadian rhythm disorders in NS, and offer a starting point for understanding the crosstalk between peripheral organs and peripheral clock systems.
format Online
Article
Text
id pubmed-6192718
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher D.A. Spandidos
record_format MEDLINE/PubMed
spelling pubmed-61927182018-10-22 An impaired hepatic clock system effects lipid metabolism in rats with nephropathy Chen, Peipei Zhang, Ruiyu Mou, Lijun Li, Xuewang Qin, Yan Li, Xuemei Int J Mol Med Articles Hyperlipidemia is a key clinical feature in patients with nephrotic syndrome (NS) that is associated with the incidence of cardiovascular events. Recent studies have suggested that the disorders of triglycerides, gluconeogenesis and liver glucose metabolism are associated with the abnormal transcription of clock genes. However, changes to the circadian rhythm of blood lipids in NS require further exploration, and the effects of NS on the hepatic clock system remain to be elucidated. In the present study, the impaired diurnal rhythm of the hepatic core clock genes (BMAL1, CLOCK, CRY1, CRY2, PER1 and PER2) significantly induced circadian rhythm abnormalities in liver-specific clock-controlled genes (LXR, CYP7A1, SREBP-1, ABCA1, DEC1 and DEC2; all P<0.05), which were significantly associated with the abnormal diurnal rhythms of triglyceride, total cholesterol, aspartate aminotransferase and alanine aminotransferase (all P<0.05) in rats with Adriamycin-induced nephropathy. Furthermore, a protein-protein interaction network was identified. Gene Ontology and Kyoto Encyclopedia of Genes and Genomes pathway analyses based on the human database was conducted to obtain signaling pathway and correlation prediction analyses of overall human clock and clock-controlled gene correlations. Strong correlations of the aforementioned clock genes were detected (avg. local clustering coefficient, 0.849) which suggested significant enrichment in circadian rhythm signaling. The present results indicated that damage to hepatic clock systems may impact blood lipid circadian rhythm disorders in NS, and offer a starting point for understanding the crosstalk between peripheral organs and peripheral clock systems. D.A. Spandidos 2018-11 2018-08-22 /pmc/articles/PMC6192718/ /pubmed/30132511 http://dx.doi.org/10.3892/ijmm.2018.3833 Text en Copyright: © Chen et al. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
spellingShingle Articles
Chen, Peipei
Zhang, Ruiyu
Mou, Lijun
Li, Xuewang
Qin, Yan
Li, Xuemei
An impaired hepatic clock system effects lipid metabolism in rats with nephropathy
title An impaired hepatic clock system effects lipid metabolism in rats with nephropathy
title_full An impaired hepatic clock system effects lipid metabolism in rats with nephropathy
title_fullStr An impaired hepatic clock system effects lipid metabolism in rats with nephropathy
title_full_unstemmed An impaired hepatic clock system effects lipid metabolism in rats with nephropathy
title_short An impaired hepatic clock system effects lipid metabolism in rats with nephropathy
title_sort impaired hepatic clock system effects lipid metabolism in rats with nephropathy
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6192718/
https://www.ncbi.nlm.nih.gov/pubmed/30132511
http://dx.doi.org/10.3892/ijmm.2018.3833
work_keys_str_mv AT chenpeipei animpairedhepaticclocksystemeffectslipidmetabolisminratswithnephropathy
AT zhangruiyu animpairedhepaticclocksystemeffectslipidmetabolisminratswithnephropathy
AT moulijun animpairedhepaticclocksystemeffectslipidmetabolisminratswithnephropathy
AT lixuewang animpairedhepaticclocksystemeffectslipidmetabolisminratswithnephropathy
AT qinyan animpairedhepaticclocksystemeffectslipidmetabolisminratswithnephropathy
AT lixuemei animpairedhepaticclocksystemeffectslipidmetabolisminratswithnephropathy
AT chenpeipei impairedhepaticclocksystemeffectslipidmetabolisminratswithnephropathy
AT zhangruiyu impairedhepaticclocksystemeffectslipidmetabolisminratswithnephropathy
AT moulijun impairedhepaticclocksystemeffectslipidmetabolisminratswithnephropathy
AT lixuewang impairedhepaticclocksystemeffectslipidmetabolisminratswithnephropathy
AT qinyan impairedhepaticclocksystemeffectslipidmetabolisminratswithnephropathy
AT lixuemei impairedhepaticclocksystemeffectslipidmetabolisminratswithnephropathy